Yorke Justin W. - 12 Oct 2023 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
12 Oct 2023
Net transactions value
+$1,800
Form type
4/A - Amendment
Filing time
23 Oct 2023, 17:31:03 UTC
Date Of Original Report
12 Oct 2023
Previous filing
10 Oct 2023
Next filing
28 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award $1,800 +6,000 +8.7% $0.3000 74,729 12 Oct 2023 Direct F1
holding PCSA Common Stock 519,890 12 Oct 2023 By Richland Fund, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amendment filed solely to correct the amount directly owned reported on the Form 4 filed October 12, 2023 and the Form 4 filed on October 10/10/2023.